Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Adama Ladu"'
Publikováno v:
British Journal of Haematology. 193:26-42
The majority of the global population of sickle cell disease (SCD) patients resides in Africa. Individuals with this condition are at great risk of serious infections and early mortality secondary to splenic dysfunction without preventative measures.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b88a35220f4eeb2f9be334445338476
https://doi.org/10.1111/bjh.17179
https://doi.org/10.1111/bjh.17179
Autor:
Aisha Mohammed Abba, Mohammed Kabir Ahmed, Usman Abjah, Adama Ladu, Audu A. Bukar, Gideon Thomas Marama, Mohammad Maina Sulaiman
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 11, Iss 1, Pp e2019010-e2019010 (2019)
Mediterranean Journal of Hematology and Infectious Diseases
Mediterranean Journal of Hematology and Infectious Diseases
Introduction: Involvement of the kidneys in patient with sickle cell anaemia is a well recognized chronic complication of this disorder. The index study seeks to determine the prevalence of chronic kidney disease in patients with homozygous sickle ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b744dec7b1b6395a7518c1e1b719b4db
https://www.mjhid.org/index.php/mjhid/article/view/3500
https://www.mjhid.org/index.php/mjhid/article/view/3500
Autor:
S.A. Asala, Ngozi Immaculata Ugwu, Biobele J. Brown, Hezekiah Isa, Yohanna Tanko, Chinatu Ohiaeri, Livingstone Gayus Dogara, Lilian Ekwem, Abdulaziz Hassan, Adekunle Adekile, Seyi Oniyangi, Obiageli E Nnodu, Aisha Kuliya-Gwarzo, Tambi Wakama, Raphael Z. Sangeda, Ijeoma N. Diaku-Akinwumi, Samuel Ademola Adegoke, Uchenna Nnebe-Agumadu, Haliru Lawal, Olaniyi Olanrewaju, Dominic Umoru, N. O. Akinola, Adama Ladu, Anazoeze Jude Madu, John Ayodele Olaniyi, Umar Kangiwa, EC Okocha, Titilope A Adeyemo, Reuben Chianumba
Publikováno v:
Blood Cells, Molecules, and Diseases. 88:102480
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63b88cd77012f900bb7b43a3e23f7e32
https://doi.org/10.1016/j.bcmd.2020.102480
https://doi.org/10.1016/j.bcmd.2020.102480
Autor:
Hezekiah Isa, Samuel Adegoke, Anazoeze Madu, Abdul-Aziz Hassan, Chinatu Ohiaeri, Reuben Chianumba, Biobele Brown, Emmanuel Okocha, Ngozi Ugwu, Ijeoma Diaku-Akinwumi, Titilope Adeyemo, Aisha Kuliya-Gwarzo, Livingstone Dogara, Haliru Lawal, Yohanna Tanko, Adama Ladu, Umar Kangiwa, Lilian Ekwem, Seyi Oniyangi, Tambi Wakama, Domic Umoru, Olaniyi Olanrewaju, Norah Akinola, Uche Nnebe-Agumadu, Samuel Asala, Adekunle Adekile, John Olaniyi, Raphael Sangeda, null Sickle Africa Data Coordinating Center (SADaCC), Obiageli Nnodu
Publikováno v:
Blood Cells Mol Dis
Background/objective Sickle cell disease (SCD) is a monogenic disease with multiple phenotypic expressions. Previous studies describing SCD clinical phenotypes in Nigeria were localized, with limited data, hence the need to understand how SCD varies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6623c2b3ef546aee7c5615f7e2591a52
https://doi.org/10.1016/j.bcmd.2020.102438
https://doi.org/10.1016/j.bcmd.2020.102438
Autor:
Usman Abjah, Adama Ladu
Publikováno v:
American Journal of Scientific and Industrial Research. 4:161-166
Sickle cell anaemia (SCA) is a genetic disorder which can be complicated by haemolytic, vasoocclusive and thrombotic processes. Antithrombin III (ATIII) is a naturally occurring anticoagulant with anti inflammatory properties. The objective of this s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90753bc1de9dfe9c5c07d1428dc57e4e
https://doi.org/10.5251/ajsir.2013.4.2.161.166
https://doi.org/10.5251/ajsir.2013.4.2.161.166